Your browser doesn't support javascript.
loading
Overexpression of VIPR2 in mice results in microencephaly with paradoxical increased white matter volume.
Ago, Yukio; Van, Christina; Condro, Michael C; Hrncir, Haley; Diep, Anna L; Rajbhandari, Abha K; Fanselow, Michael S; Hashimoto, Hitoshi; MacKenzie-Graham, Allan J; Waschek, James A.
Afiliação
  • Ago Y; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka Un
  • Van C; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; Molecular Biology Interdepartmental Doctoral Program, University of California Los Angeles, Los
  • Condro MC; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University o
  • Hrncir H; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, University of California Los Angeles, Los Angeles, CA 90095, USA.
  • Diep AL; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
  • Rajbhandari AK; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; Department of Psychology, Brain Research Institute, University of California Los Angeles, Los A
  • Fanselow MS; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA; Department of Psychology, Brain Research Institute, University of California Los Angeles, Los A
  • Hashimoto H; Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University
  • MacKenzie-Graham AJ; Ahmanson-Lovelace Brain Mapping Center, Department of Neurology, University of California Los Angeles, Los Angeles, CA 90095, USA.
  • Waschek JA; Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA. Electronic address: jwaschek@mednet.ucla.edu.
Exp Neurol ; 362: 114339, 2023 04.
Article em En | MEDLINE | ID: mdl-36717013
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Tipo II de Peptídeo Intestinal Vasoativo / Substância Branca Limite: Animals / Female / Humans / Male Idioma: En Revista: Exp Neurol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores Tipo II de Peptídeo Intestinal Vasoativo / Substância Branca Limite: Animals / Female / Humans / Male Idioma: En Revista: Exp Neurol Ano de publicação: 2023 Tipo de documento: Article